Important Information Related to Your Request:
The material below is provided in response to your specific search for information on UCBCOMPASS® and may contain information that is not part of the FDA-approved Prescribing Information. UCB, Inc. does not recommend or endorse the use of its products in a manner not consistent with the approved Prescribing Information. Please review the Full Prescribing Information.
Chapters
Name
Welcome, Disclosures, Agenda
Chapter Time
00:00:00
Chapter Seconds
0
Name
Burden of Disease in PsA and axSpA
Chapter Time
00:07:08
Chapter Seconds
428
Name
Drivers of Disease Burden
Chapter Time
00:13:09
Chapter Seconds
789
Name
Inflammatory Pathways of PsA and axSpA
Chapter Time
00:20:54
Chapter Seconds
1254
Name
The IL-17 Cytokine Family
Chapter Time
00:22:17
Chapter Seconds
1337
Name
Innate and Adaptive Pathways
Chapter Time
00:27:01
Chapter Seconds
1621
Name
Role of IL-17A and IL-17F in PsA and axSpA
Chapter Time
00:28:56
Chapter Seconds
1736
Name
Is Early Control of Inflammation the Missing Piece?
Chapter Time
00.37:07
Chapter Seconds
2227
Name
Summary of the Treatment Guidelines in PsA and axSpA
Chapter Time
00:39:19
Chapter Seconds
2359
Name
Association Between Inflammation and Worse Outcomes
Chapter Time
00:39:54
Chapter Seconds
2394
Name
Importance of Early Control of Inflammation
Chapter Time
00:42:08
Chapter Seconds
2528
Name
Early and Appropriate Intervention and Improved Outcomes
Chapter Time
00:49:42
Chapter Seconds
2982
Name
The Rationale for Early Inflammation Control
Chapter Time
00:50:32
Chapter Seconds
3032